Ten-week program aims to help trade union members in Hamilton kick their smoking habit
MARKHAM, ON, July 13, 2017 /CNW/ - McNeil Consumer Healthcare, a division of Johnson & Johnson Inc. (J&J), is launching a smoking cessation program to help a group of Hamiltonians quit smoking with a new approach called Combination Therapy. Recently authorized by Health Canada, the approach includes use of the NICODERM® patch for ongoing support, combined with NICORETTE® oral products to help control the sudden cravings that make quitting so difficult.
Eleven members of the United Association of Journeymen and Apprentices of the Plumbing and Pipe Fitting Industry Local 67 are beginning their 10-week nicotine replacement therapy (NRT) smoking cessation challenge. J&J is providing NRT product to support each of these individuals on their journeys.
"Our union prioritizes the health of our members and recognizes that many smoke regularly," says Geoff Roman of Local 67. "We're excited to launch this first-of-its kind program to encourage our members to quit together as a team, and hopefully see a ripple effect in the community."
Twenty-two per cent of the population in Hamilton smoke,i demonstrating a higher rate compared to the rest of Canada with an average rate of 15 per cent.ii
"J&J is proud to sponsor this pilot program as part of our mission to enrich the health and wellness of every Canadian, every day," notes Zack Grossman, senior brand manager of smoking cessation at Johnson & Johnson Inc. "We envision a smoke-free country and are excited to take this step to help Canadians get one step closer to this."
About Combination Therapy
Canadians now have a better chance at quitting with a newly approved method. Combination Therapy, recently authorized by Health Canada, includes the use of the NICODERM® patch for ongoing support, combined with the use of NICORETTE® Gum, Lozenge or QuickMist®, to help control the sudden cravings that make quitting so difficult.
While using a single product works for many, Combination Therapy is nearly 40 per cent* more effective than using only one nicotine replacement therapy (NRT) format at a time.iii
For more information, talk to your pharmacist or physician about NRT Combination Therapy to find your proper dose for your best chance of success.
About Johnson & Johnson Inc.
Johnson & Johnson Inc. (Markham, Ontario) is a member of the Johnson & Johnson Family of Companies, the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. Johnson & Johnson Inc. markets leading and innovative products in the skin and hair care, baby care, wound care, oral health care, nicotine replacement therapy and over-the-counter medicine categories. Our mission is to care for people by anticipating their needs, creating solutions and experiences that help them and those they care for, live healthy, vibrant lives.
*with NICORETTE® gum
i Ontario Tobacco Research Unit. OTRU Update. http://otru.org/wp-content/uploads/2014/06/update_june2014.pdf. June 2014.
ii Statistics Canada. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/health74b-eng.htm.
iii Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-‐analysis. Cochrane Database of Systematic Reviews 2013, Issue 5; Page 18 Fig 4
For further information: please contact: Jeremy Brace, Johnson & Johnson Inc., 905-968-2098, email@example.com; Jillian Pastirik, Edelman Public Relations, 416-849-1518, Jillian.firstname.lastname@example.org